Entrada Therapeutics Stock Price History
TRDA Stock | USD 12.12 0.10 0.83% |
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 12.12, as last reported on the 27th of February, with the highest price reaching 12.12 and the lowest price hitting 12.02 during the day. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of -0.22, which denotes the company had a -0.22 % return per unit of risk over the last 3 months. Entrada Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entrada Therapeutics' Standard Deviation of 3.43, variance of 11.78, and Mean Deviation of 2.57 to check the risk estimate we provide.
At present, Entrada Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.76, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Entrada |
Sharpe Ratio = -0.2238
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TRDA |
Estimated Market Risk
3.52 actual daily | 31 69% of assets are more volatile |
Expected Return
-0.79 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Entrada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding Entrada Therapeutics to a well-diversified portfolio.
Price Book 1.0736 | Enterprise Value Ebitda 1.0685 | Price Sales 2.1072 | Shares Float 18.7 M | Wall Street Target Price 26.9275 |
Entrada Therapeutics Stock Price History Chart
There are several ways to analyze Entrada Stock price data. The simplest method is using a basic Entrada candlestick price chart, which shows Entrada Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 6, 2024 | 21.59 |
Lowest Price | February 26, 2025 | 12.02 |
Entrada Therapeutics February 27, 2025 Stock Price Synopsis
Various analyses of Entrada Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Entrada Stock. It can be used to describe the percentage change in the price of Entrada Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Entrada Stock.Entrada Therapeutics Price Action Indicator | 0.10 | |
Entrada Therapeutics Price Daily Balance Of Power | 1.00 | |
Entrada Therapeutics Price Rate Of Daily Change | 1.01 |
Entrada Therapeutics February 27, 2025 Stock Price Analysis
Entrada Stock Price History Data
The price series of Entrada Therapeutics for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 9.57 with a coefficient of variation of 18.86. The price distribution for the period has arithmetic mean of 15.87. The median price for the last 90 days is 17.1.Open | High | Low | Close | Volume | ||
02/27/2025 | 12.02 | 12.12 | 12.02 | 12.12 | ||
02/26/2025 | 12.11 | 12.51 | 11.91 | 12.02 | 88,364 | |
02/25/2025 | 13.04 | 13.17 | 12.12 | 12.12 | 105,762 | |
02/24/2025 | 13.61 | 13.82 | 12.84 | 12.85 | 158,082 | |
02/21/2025 | 13.32 | 13.40 | 12.97 | 13.04 | 96,612 | |
02/20/2025 | 12.95 | 13.28 | 12.70 | 13.07 | 75,054 | |
02/19/2025 | 13.01 | 13.22 | 12.70 | 13.00 | 93,606 | |
02/18/2025 | 13.53 | 13.62 | 12.77 | 13.09 | 101,782 | |
02/14/2025 | 12.66 | 13.44 | 12.66 | 13.44 | 115,239 | |
02/13/2025 | 12.79 | 12.85 | 12.57 | 12.63 | 59,413 | |
02/12/2025 | 12.01 | 13.00 | 12.01 | 12.69 | 115,156 | |
02/11/2025 | 12.67 | 12.91 | 12.06 | 12.24 | 168,453 | |
02/10/2025 | 12.97 | 13.17 | 12.73 | 12.86 | 80,564 | |
02/07/2025 | 13.50 | 13.62 | 12.74 | 12.94 | 96,356 | |
02/06/2025 | 14.00 | 14.02 | 13.38 | 13.48 | 117,938 | |
02/05/2025 | 13.60 | 14.27 | 13.49 | 13.99 | 66,892 | |
02/04/2025 | 13.39 | 13.75 | 13.39 | 13.56 | 98,324 | |
02/03/2025 | 12.85 | 13.63 | 12.53 | 13.33 | 106,335 | |
01/31/2025 | 13.53 | 13.84 | 13.33 | 13.44 | 116,631 | |
01/30/2025 | 13.49 | 13.65 | 13.24 | 13.37 | 100,018 | |
01/29/2025 | 13.05 | 13.30 | 12.90 | 13.26 | 66,543 | |
01/28/2025 | 13.16 | 13.37 | 12.79 | 13.05 | 84,785 | |
01/27/2025 | 12.72 | 13.29 | 12.72 | 13.18 | 111,856 | |
01/24/2025 | 12.70 | 12.93 | 12.51 | 12.84 | 94,559 | |
01/23/2025 | 12.49 | 13.09 | 12.39 | 12.92 | 187,566 | |
01/22/2025 | 13.06 | 13.46 | 12.54 | 12.54 | 151,978 | |
01/21/2025 | 12.83 | 13.15 | 12.71 | 13.06 | 95,629 | |
01/17/2025 | 12.69 | 12.73 | 12.49 | 12.69 | 106,644 | |
01/16/2025 | 12.12 | 12.72 | 12.02 | 12.54 | 163,204 | |
01/15/2025 | 12.96 | 13.02 | 12.20 | 12.25 | 117,464 | |
01/14/2025 | 13.44 | 13.67 | 12.35 | 12.49 | 177,577 | |
01/13/2025 | 14.47 | 14.47 | 13.16 | 13.37 | 121,724 | |
01/10/2025 | 16.00 | 16.07 | 14.60 | 14.65 | 187,146 | |
01/08/2025 | 17.15 | 17.15 | 16.19 | 16.22 | 114,243 | |
01/07/2025 | 17.97 | 18.42 | 17.11 | 17.25 | 122,804 | |
01/06/2025 | 18.75 | 18.75 | 18.04 | 18.05 | 75,002 | |
01/03/2025 | 17.69 | 18.76 | 17.63 | 18.31 | 120,113 | |
01/02/2025 | 17.41 | 18.01 | 17.13 | 17.46 | 155,309 | |
12/31/2024 | 17.49 | 17.80 | 17.23 | 17.29 | 116,097 | |
12/30/2024 | 17.38 | 17.74 | 16.81 | 17.37 | 105,291 | |
12/27/2024 | 17.62 | 17.84 | 17.21 | 17.41 | 76,441 | |
12/26/2024 | 17.48 | 17.80 | 17.11 | 17.74 | 48,334 | |
12/24/2024 | 17.50 | 17.71 | 17.02 | 17.56 | 38,970 | |
12/23/2024 | 17.48 | 17.67 | 17.02 | 17.46 | 87,102 | |
12/20/2024 | 16.86 | 18.00 | 16.86 | 17.59 | 357,928 | |
12/19/2024 | 17.11 | 17.68 | 16.86 | 17.28 | 125,259 | |
12/18/2024 | 18.50 | 18.96 | 17.00 | 17.10 | 149,682 | |
12/17/2024 | 17.89 | 18.54 | 17.83 | 18.45 | 91,373 | |
12/16/2024 | 17.61 | 18.46 | 17.28 | 18.01 | 103,670 | |
12/13/2024 | 17.93 | 17.93 | 17.26 | 17.66 | 111,157 | |
12/12/2024 | 19.74 | 19.93 | 18.05 | 18.12 | 88,478 | |
12/11/2024 | 20.53 | 21.08 | 19.86 | 19.90 | 125,106 | |
12/10/2024 | 21.37 | 21.46 | 20.37 | 20.51 | 125,886 | |
12/09/2024 | 21.75 | 21.79 | 21.19 | 21.52 | 110,307 | |
12/06/2024 | 20.81 | 21.63 | 20.48 | 21.59 | 81,524 | |
12/05/2024 | 19.90 | 20.46 | 19.58 | 20.32 | 119,826 | |
12/04/2024 | 20.18 | 20.26 | 19.60 | 19.96 | 141,511 | |
12/03/2024 | 20.32 | 20.50 | 19.98 | 20.17 | 161,090 | |
12/02/2024 | 19.99 | 20.50 | 19.65 | 20.32 | 170,715 | |
11/29/2024 | 19.83 | 20.02 | 19.52 | 19.89 | 78,388 | |
11/27/2024 | 19.55 | 19.93 | 19.30 | 19.83 | 124,306 |
About Entrada Therapeutics Stock history
Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 38 M | 34.8 M | |
Net Loss | -85.2 M | -80.9 M |
Entrada Therapeutics Quarterly Net Working Capital |
|
Entrada Therapeutics Stock Technical Analysis
Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Entrada Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.11) | |||
Jensen Alpha | (0.54) | |||
Total Risk Alpha | (0.51) | |||
Treynor Ratio | (1.31) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Entrada Stock analysis
When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |